EBV never fully leaves the body, but it doesn't have to keep driving your symptoms.
Epstein-Barr Virus infects an estimated 95% of people during their lifetime, most often presenting as mononucleosis in adolescence or early adulthood. What most people, and many practitioners, don't know is that EBV never fully clears. It takes up residence within B-cell immune tissue, where it can lie dormant for years before reactivating when the immune system is under stress.
Reactivated EBV is directly linked to several autoimmune conditions including Hashimoto's thyroiditis, Sjogren's syndrome, and rheumatoid arthritis, because EBV reprograms immune cells in ways that blur the line between fighting infection and attacking self. Root cause work focuses on reducing viral burden, supporting immune resilience, and preventing cycles of ongoing reactivation.
Around 95% of individuals will encounter the Epstein Barr Virus (EBV) at some point in their lives. Interestingly, symptoms associated with EBV often manifest more severely in adulthood, persisting for extended periods. This virus has the ability to conceal itself within immune cells, prompting a recalibration of the cell's functions and leading to a compromised immune system. The ensuing havoc includes symptoms such as profound fatigue, body aches, weakened immunity, and impacts on the heart and brain.
For every 4 young adults contracting EBV, 1 is likely to develop infectious mononucleosis, with symptoms typically emerging 4-6 weeks after EBV exposure. EBV's influence extends to altering the host's immune response, rendering it more susceptible to other viruses and hindering programmed cell death (apoptosis). This viral connection is associated with autoimmune conditions such as Sjogren's syndrome, rheumatoid arthritis, and autoimmune thyroiditis.
EBV can lead to so-called "random" and stubborn symptoms that leave many people stumped.
Dr. Jaban Moore
EBV may lay dormant for an extended period, only to reactivate later, potentially causing intermittent flare-ups over the years. In 20% of the population, certain antibody levels persist at elevated levels for an extended duration, making it easy to mistake reactivated EBV for a new or unrelated condition.
Because EBV conceals itself within immune cells (particularly B cells) and undergoes reprogramming that diminishes the immune system, standard testing doesn't always reveal the full picture of what the virus is doing inside the body.
Testing for Epstein-Barr Virus typically involves several methods to determine if a person has been infected. Serological tests include Viral Capsid Antigen (VCA) IgM and IgG antibodies, Early Antigen (EA-D) IgG, and Nuclear Antigen (EBNA) IgG. PCR testing can detect the genetic material of the virus and is useful for confirming an active infection. The Monospot Test detects heterophile antibodies produced during an EBV infection.
Blood tests may show elevated lymphocyte levels and reduced counts of neutrophils or platelets. EBV antibody blood tests are effective in unveiling past, recent, or ongoing infections, including reactivation. At The Redefining Wellness Center, we highly urge you to work with a practitioner when investigating EBV.